Gillies Hunter — SEC Form 4 filings
SEC reporting owner CIK 1868997. 10 Form 4 filings on record with FilingPulse; latest filed 2024-06-14.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-19 to 2024-06-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 9 filings — 46,975 shares, $1,145,836 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 9,000 shares @ $29.50 ($265,500) in Aerovate Therapeutics, Inc., filed 2024-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aerovate Therapeutics, Inc. (AVTE) | CHIEF MEDICAL OFFICER | 10 | — | 13 legs · 46,975 sh · $1,145,836 | 24 |
Form 4 filings — Gillies Hunter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-14 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 6,000 @ $2.14 · Sale (S): 6,000 @ $24.50 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 4,000 @ $2.14 · Sale (S): 3,914 @ $21.07 · Sale (S): 86 @ $21.86 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 4,000 @ $1.74 · Sale (S): 3,689 @ $22.30 · Sale (S): 311 @ $23.33 · Option exercise (M): 503 (derivative) @ $0 · Option exercise (M): 3,497 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 9,000 @ $2.14 · Sale (S): 9,000 @ $29.50 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 4,000 @ $1.74 · Option exercise (M): 3,000 @ $2.14 · Sale (S): 6,387 @ $25.81 · Sale (S): 613 @ $26.40 · Option exercise (M): 4,000 (derivative) @ $0 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 8,975 @ $2.14 · Sale (S): 8,975 @ $24.50 · Option exercise (M): 945 (derivative) @ $0 · Option exercise (M): 8,030 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 511 @ $1.74 · Sale (S): 511 @ $19.50 · Option exercise (M): 511 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 3,489 @ $1.74 · Sale (S): 2,591 @ $20.11 · Sale (S): 898 @ $20.58 · Option exercise (M): 2,502 (derivative) @ $0 · Option exercise (M): 987 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 4,000 @ $1.74 · Sale (S): 4,000 @ $19.50 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1868997 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →